Carlisle Companies News

Carlisle Companies Aktie VALOR 916251 / ISIN US1423391002

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Trading-Depot

Aktion

Portfolio

Watchlist

15.03.18	CSL Behring Receives Patient Impact Award For Subcutaneous Prophylactic Treatment To Prevent Hereditary Angioedema Attacks (PR Newswire)
13.03.18	CSL CEO Paul Perreault Calls on Industry to Improve Patients' Access to Medicines (PR Newswire)
13.03.18	CSL CEO Paul Perreault Calls on Industry to Improve Patients' Access to Medicines (PR Newswire)
13.03.18	Seqirus answers the call for better and faster influenza vaccine technologies (PR Newswire)
07.03.18	CFSP Acquisition Corp. -- Moody's assigns B3 CFR to Carlisle FoodService; B2 to secured first lien facility (Moodys)
08.02.18	Carlisle Companies Inc. Bottom Line Advances In Q4 (RTTNews)
01.02.18	Carlisle Companies To Sell Carlisle FoodService Products For $750 Mln In Cash (RTTNews)
07.12.17	Rogers Communications announces changes to Board of Directors (PR Newswire)
05.12.17	CSL and Vitaeris Announce Strategic Partnership with Option to Acquire (PR Newswire)
05.12.17	CSL and Vitaeris Announce Strategic Partnership with Option to Acquire (PR Newswire)
05.12.17	CSL and Vitaeris Announce Strategic Partnership with Option to Acquire (PR Newswire)
04.12.17	CSL Behring Advances to Phase 3 Cardiovascular Outcomes Trial for CSL112, its Novel Apolipoprotein A-I (Human) Infusion Therapy (PR Newswire)
16.11.17	SQI Diagnostics Reports Fourth Quarter and Fiscal 2017 Results (PR Newswire)
13.11.17	Carlisle Companies Incorporated -- Moody's affirms Carlisle Companies' Baa2 senior unsecured rating; assigns Baa2 senior unsecured rating to proposed notes issuance (Moodys)
09.11.17	Lancet Neurology Publishes Results from CSL Behring Phase III Study of Hizentra® (Immune Globulin Subcutaneous [Human] 20% liquid) as Maintenance Therapy in Patients with Chronic Inflammatory... (PR Newswire)
29.10.17	Data on the Preventive Effects of HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) in Subjects with Very Frequent HAE Attacks Presented by CSL Behring at the 2017 ACAAI Annual Scientific Meeting (PR Newswire)
24.10.17	Carlisle Companies Inc. Q3 Earnings Decline 24% (RTTNews)
24.10.17	New Data for HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) to be presented at the 2017 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting (PR Newswire)
12.10.17	CSL Behring Trains Employees to Save Lives in Their Communities and Workplace with CPR; AHA Encourages Other Businesses to Do the Same (PR Newswire)
02.10.17	Carlisle To Acquire Accella For $670 Mln - Quick Facts (RTTNews)
02.10.17	Arsenal Announces Sale of Accella Performance Materials to Carlisle Companies (PR Newswire)
28.09.17	Japan's Ministry of Health, Labour and Welfare Approves AFSTYLA® - CSL Behring's Novel Recombinant Haemophilia A Treatment (PR Newswire)
22.09.17	Moody's upgrades perspective to stable and confirms Ecopetrol S.A.'s investment-grade rating (PR Newswire)
19.09.17	CSL Behring Will Help Transform Biotech Education and Research with $4.92 Million Gift to Penn State (PR Newswire)
15.09.17	CSL Behring Announces FDA Approval of Privigen® [Immune Globulin Intravenous (Human), 10% Liquid] for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Adults (PR Newswire)
14.09.17	CSL Behring Joins Together With Conference Attendees to Make Donation to IPOPI (PR Newswire)
08.09.17	Design and Construction Amnesia: Liberty Building Forensics Group Says, "We Have Lost our Minds and it is Causing Catastrophic Mold and Moisture Building Failures." (PR Newswire)
08.09.17	Initiating Research Reports on Rubber & Plastics Equities -- Goodyear Tire & Rubber, Carlisle, Cooper Tire & Rubber, and Trinseo (PR Newswire)
01.09.17	SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory Asset Partners, LLC and the Gregory Irrevocable Equalizing Trust, acting jointly Files Early Warning Report (PR Newswire)
28.08.17	CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform (PR Newswire)
22.08.17	Clutch Announces Top Agencies and Developers in Philadelphia and Atlanta (PR Newswire)
25.07.17	Carlisle Companies Inc. Profit Drops 11% In Q2 (RTTNews)
25.07.17	HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) Now Available in the United States for Patients with Hereditary Angioedema (PR Newswire)
21.07.17	CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) (PR Newswire)
19.07.17	FDA Accepts CSL Behring's Supplemental Biologics License Application for Hizentra® Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Indication (PR Newswire)
12.07.17	New Data Demonstrate Prophylactic Treatment with IDELVION® Reduces Bleed Frequency and Has Potential to Positively Impact Patients with Haemophilia B (PR Newswire)
11.07.17	CSL Behring Awards Researchers to Advance Immunoglobulin Therapy in Treating Neurological Disorders (PR Newswire)
10.07.17	New Findings Show AFSTYLA® Provides Long-lasting Efficacy without Increased Product Consumption for Prophylactic and On-Demand Treatment of Haemophilia A (PR Newswire)
06.07.17	New Data for Two Leading Haemophilia Medicines -- AFSTYLA® and IDELVION® -- to be Presented at the International Society on Thrombosis and Haemostasis Congress 2017 (PR Newswire)
30.06.17	How These Rubber and Plastics Stocks are Performing? -- Goodyear Tire & Rubber, Carlisle, Cooper Tire & Rubber, and Trinseo (PR Newswire)
23.06.17	FDA Approves HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]), First and Only Subcutaneous Preventive Treatment for Hereditary Angioedema (PR Newswire)
13.06.17	CSL to acquire majority stake in Chinese plasma fractionator Wuhan Zhong Yuan Rui De Biologicals Products (PR Newswire)
19.05.17	New Innovation in the Fight Against Hemophilia Earns CSL Behring the NORD 2017 Industry Innovation Award (PR Newswire)
28.04.17	Carlisle Companies Inc. Q1 Income Declines 10% (RTTNews)
25.04.17	Wirecard North America and CSL Plasma Launch First Cash-Back Donor Prepaid Card (PR Newswire)
25.04.17	Wirecard North America and CSL Plasma Launch First Cash-Back Donor Prepaid Card (PR Newswire)
19.04.17	Therapeutic Goods Administration Approves AFSTYLA® - CSL Behring's Novel Recombinant Haemophilia A Treatment (PR Newswire)
10.04.17	Improving Access to Lifesaving Treatments for Bleeding Disorders in the Developing World (PR Newswire)
07.04.17	Technical Reports on Consumer Goods Equities -- Travelport, Liberty TripAdvisor, Brunswick, and Carlisle (PR Newswire)
31.03.17	Jeffrey Modell Foundation to Open the First North African Network for Primary Immunodeficiencies (PR Newswire)

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	25.43	0.08 %	K V
Nestle	88.15	-0.01 %	K V
Zurich Insur Gr	593.20	-0.07 %	K V
Logitech Intl	63.36	-0.13 %	K V
Swiss Life Hldg	842.80	-0.38 %	K V
CieFinRichemont	143.15	-1.82 %	K V
Roche Hldg G	266.20	-1.92 %	K V
Part Grp Hldg	1’073.00	-2.14 %	K V
Lonza Grp	577.80	-2.50 %	K V
Kuehne+Nagel Int	182.75	-2.77 %	K V